GlassScriptPhysician profile
Baljinder S Gill
NPI 1790774784
$4,559.64
in general payments reported to CMS, 2019-2025
41 companies · $248 in 2025
The $248 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $872 · 2020: $573 · 2021: $595 · 2022: $950 · 2023: $724 · 2024: $599 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,491 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,490.72 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $813.00 | 2021-2023 | |
| Glaxosmithkline, LLC. | $491.02 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $471.87 | 2019-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $331.47 | 2019-2024 | Breztri, Farxiga |
| Lilly USA, LLC | $264.66 | 2020-2025 | Mounjaro, Kisunla, Trulicity |
| Allergan, INC. | $248.55 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $237.51 | 2019-2022 | |
| Pfizer INC. | $195.77 | 2019-2024 | |
| Amgen INC. | $174.23 | 2020-2024 | Prolia, Evenity |
| Novartis Pharmaceuticals Corporation | $99.48 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $97.76 | 2019-2024 | Spravato |
| Merck Sharp & Dohme LLC | $96.97 | 2020-2021 | |
| Exact Sciences Corporation | $81.71 | 2023-2025 | Cologuard Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $81.63 | 2019-2022 | |
| Astellas Pharma US INC | $79.99 | 2023 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Baljinder Gill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.